Sandbox:Roukoz: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="4" |'''Clinical manifestations'''
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="4" rowspan="2" |Para-clinical findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Examination
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Examination
|-
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" |Lab Findings
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
|-  
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Color
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Risk factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin exam 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin exam 1
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin exam 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin exam 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Risk factors
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Areas affected
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Areas affected
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unique features
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unique features
Line 25: Line 22:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''SCC in situ (Bowen's disease''')
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''SCC in situ (Bowen's disease''')
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Usually asymptomatic
* Well-demarcated, scaly patch or plaque
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Erythematous
* Skin colored
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Well-demarcated, scaly patch or plaque
*  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hyperkeratotic, or ulcerative lesions
* Hyperkeratotic, or ulcerative lesions
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Lesions are often erythematous but can also be skin colored or pigmented.
| style="background: #F5F5F5; padding: 5px;" |
* none
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Any cutaneous surface, including the head, neck, trunk, extremities, oral mucosa, shoulders, chest and back
* Any cutaneous surface, including the head, neck, trunk, extremities, oral mucosa, shoulders, chest and back
Line 51: Line 46:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Invasive squamous cell carcinoma'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Invasive squamous cell carcinoma'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Usually asymptomatic
* Papules
* Plaques
* Nodules
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Poorly differentiated lesions are usually fleshy, soft, granulomatous papules or nodules that lack the hyperkeratosis that is often seen in well-differentiated lesions
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* White circles, keratin, blood spots, and white structureless zones
* none
| style="background: #F5F5F5; padding: 5px;" |
* Well-differentiated lesions usually appear as indurated or firm, hyperkeratotic papules, plaques, or nodules
| style="background: #F5F5F5; padding: 5px;" |
* Poorly differentiated lesions are usually fleshy, soft, granulomatous papules or nodules that lack the hyperkeratosis that is often seen in well-differentiated lesions
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Poorly differentiated tumors may have ulceration, hemorrhage, or areas of necrosis.
* Poorly differentiated tumors may have ulceration, hemorrhage, or areas of necrosis.
* Well-differentiated lesions usually appear as indurated or firm, hyperkeratotic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* none
* White circles, keratin, blood spots, and white structureless zones
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* same as above
* same as above
Line 70: Line 65:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |White circles, keratin, blood spots, and white structureless zones
| style="background: #F5F5F5; padding: 5px;" |Initial lesion: small pink macule  
| style="background: #F5F5F5; padding: 5px;" |Initial lesion: small pink macule  


Later: papular quality and eventually forms a circumscribed nodule.
Later: papular quality and eventually forms a circumscribed nodule.
| style="background: #F5F5F5; padding: 5px;" |The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias
| style="background: #F5F5F5; padding: 5px;" |The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias
| style="background: #F5F5F5; padding: 5px;" |The center of the nodule typically demonstrates a prominent keratinous core.
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Skin color
* Skin color
Line 86: Line 77:
* Chemical carcinogens (tar, pitch, polyaromatic hydrocarbons)
* Chemical carcinogens (tar, pitch, polyaromatic hydrocarbons)
* Human papillomavirus infection
* Human papillomavirus infection
| style="background: #F5F5F5; padding: 5px;" |The center of the nodule typically demonstrates a prominent keratinous core.
| style="background: #F5F5F5; padding: 5px;" |White circles, keratin, blood spots, and white structureless zones
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Develops on sun-exposed areas of the skin.
* Develops on sun-exposed areas of the skin.
Line 104: Line 97:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Milky red areas; linear, irregular vessels; and polymorphous vessels
| style="background: #F5F5F5; padding: 5px;" |rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule
| style="background: #F5F5F5; padding: 5px;" |rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |Older patients with light skin tones
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |Older patients with light skin tones
| style="background: #F5F5F5; padding: 5px;" |Milky red areas; linear, irregular vessels; and polymorphous vessels
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Starts on areas of skin exposed to the sun
* Starts on areas of skin exposed to the sun
Line 122: Line 113:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias
| style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias
| style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule
| style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Typically presents on the face
| style="background: #F5F5F5; padding: 5px;" |Typically presents on the face
| style="background: #F5F5F5; padding: 5px;" |May have a "rolled" border, where the periphery is more raised than the middle.
| style="background: #F5F5F5; padding: 5px;" |May have a "rolled" border, where the periphery is more raised than the middle.
Line 135: Line 124:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma '''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma '''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Scaly patch
| style="background: #F5F5F5; padding: 5px;" |Scaly patch
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 150: Line 137:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Firm, dome-shaped and itchy
| style="background: #F5F5F5; padding: 5px;" |Firm, dome-shaped and itchy
| style="background: #F5F5F5; padding: 5px;" |ranging in size from a few millimeters to several centimeters and often symmetrically distributed
| style="background: #F5F5F5; padding: 5px;" |ranging in size from a few millimeters to several centimeters and often symmetrically distributed
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |Nodules can be flesh-colored, erythematous, or brown/black  
| style="background: #F5F5F5; padding: 5px;" |Nodules can be flesh-colored, erythematous, or brown/black  
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Extensor surfaces of the arms and legs and on the trunk
* Extensor surfaces of the arms and legs and on the trunk
Line 173: Line 158:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus'''
| style="background: #F5F5F5; padding: 5px;" |
* Dome-shaped, usually nonpigmented or hypopigmented nodules with a smooth surface
| style="background: #F5F5F5; padding: 5px;" |
* Terminal hairs are often present
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 179: Line 168:
* Structureless skin-colored to light brown background pigmentation
* Structureless skin-colored to light brown background pigmentation
* Residual brown globules (clods) or brown thick circles, mainly located around the hair follicles can sometimes be seen
* Residual brown globules (clods) or brown thick circles, mainly located around the hair follicles can sometimes be seen
| style="background: #F5F5F5; padding: 5px;" |
* Dome-shaped, usually nonpigmented or hypopigmented nodules with a smooth surface
| style="background: #F5F5F5; padding: 5px;" |
* Terminal hairs are often present
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Bluish macules or papules
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 196: Line 182:
* Structureless blue pigmentation
* Structureless blue pigmentation
* Structureless blue and white or blue and brown on some occasions
* Structureless blue and white or blue and brown on some occasions
| style="background: #F5F5F5; padding: 5px;" |
* Bluish macules or papules
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Head and neck,  
* Head and neck,  
Line 211: Line 192:
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Spitz nevus'''
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Spitz nevus'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nonpigmented Spitz nevus'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nonpigmented Spitz nevus'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 224: Line 203:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Reed-like Spitz'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Reed-like Spitz'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 237: Line 214:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 250: Line 225:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 263: Line 236:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna Melanoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna Melanoma'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 276: Line 247:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 289: Line 258:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 302: Line 269:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic keratosis'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic keratosis'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 315: Line 280:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size.
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size.
| style="background: #F5F5F5; padding: 5px;" |Erythema
| style="background: #F5F5F5; padding: 5px;" |Erythema
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 328: Line 291:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular malignant melanoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular malignant melanoma'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |No more additional findings
| style="background: #F5F5F5; padding: 5px;" |none
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 343: Line 304:
|-
|-
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma'''
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma'''
| style="background: #F5F5F5; padding: 5px;" |Usually asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color
| style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 00:47, 19 February 2019

Diseases Clinical manifestations Para-clinical findings Additional findings
Skin Examination
Lab Findings Histopathology
Type Color Risk factors Skin exam 3 Dermoscopic Findings Areas affected Unique features
Cutaneous squamous cell carcinoma SCC in situ (Bowen's disease)
  • Well-demarcated, scaly patch or plaque
  • Erythematous
  • Skin colored
  • Hyperkeratotic, or ulcerative lesions
  • Any cutaneous surface, including the head, neck, trunk, extremities, oral mucosa, shoulders, chest and back
  • In fair-skinned individuals, SCCs most commonly arise in sites frequently exposed to the sun
  • In black individuals, common sites for SCC include the legs, anus, and areas of chronic inflammation or scarring
  • Keratinocytic dysplasia involving the full thickness of the epidermis without infiltration of atypical cells into the dermis
  • The keratinocytes are pleomorphic with hyperchromatic nuclei, and numerous mitoses are present.
  • SCC in situ lesions tend to grow slowly, enlarging over the course of years
Invasive squamous cell carcinoma
  • Papules
  • Plaques
  • Nodules
  • Poorly differentiated lesions are usually fleshy, soft, granulomatous papules or nodules that lack the hyperkeratosis that is often seen in well-differentiated lesions
  • none
  • Poorly differentiated tumors may have ulceration, hemorrhage, or areas of necrosis.
  • Well-differentiated lesions usually appear as indurated or firm, hyperkeratotic
  • White circles, keratin, blood spots, and white structureless zones
  • same as above
same as above same as above same as above
Keratoacanthoma Initial lesion: small pink macule

Later: papular quality and eventually forms a circumscribed nodule.

The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias
  • Skin color
  • Ultraviolet radiation
  • Genetics
  • Drug exposure (BRAF inhibitors)
  • Trauma (surgery, laser therapy, cryotherapy or accidental trauma)
  • Chemical carcinogens (tar, pitch, polyaromatic hydrocarbons)
  • Human papillomavirus infection
The center of the nodule typically demonstrates a prominent keratinous core. White circles, keratin, blood spots, and white structureless zones
  • Develops on sun-exposed areas of the skin.
  • The face (especially the eyelids, nose, cheek, and lower lip), neck, hands, and arms are common sites for involvement
a history of rapid growth within weeks favors this diagnosis
  • Epidermal hyperplasia with large eosinophilic keratinocytes
  • Central invagination with a keratotic core (in later stages)
  • "Lipping" or "buttressing" of the epidermis over the peripheral rim of the central keratotic plug
  • Sharp demarcation between the tumor and the surrounding stroma
  • Mixed inflammatory infiltrate in the dermis
  • It is controversial whether keratoacanthomas represent a subtype of well-differentiated SCC or a separate entity
Merkel cell carcinoma rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule No more additional findings Older patients with light skin tones No more additional findings Milky red areas; linear, irregular vessels; and polymorphous vessels
  • Starts on areas of skin exposed to the sun
  • Most frequent locations for the primary tumor are head and neck, upper limbs and shoulder, lower limbs and hip, and trunk
  • Strands or nests of monotonously uniform, round, blue cells, containing large basophilic nuclei with powdery dispersed chromatin and inconspicuous nucleoli, and minimal cytoplasm
  • Single-cell necrosis, frequent mitoses, lymphovascular invasion, perineural invasion, and epidermal involvement via pagetoid spread.
Blue-red, dome-shaped nodule
Nodular basal cell carcinoma Pearly papule with telangiectasias Pink or flesh-colored papule none No more additional findings Typically presents on the face May have a "rolled" border, where the periphery is more raised than the middle. Ulceration is frequent, and the term "rodent ulcer" refers to these ulcerated nodular BCCs
Superficial basal cell carcinoma Scaly patch Erythematous lesion No more additional findings
  • large, hyperchromatic, oval nuclei and little cytoplasm
  • well differentiated and cells appear histologically similar to basal cells of the epidermis
Prurigo nodules Firm, dome-shaped and itchy ranging in size from a few millimeters to several centimeters and often symmetrically distributed none Nodules can be flesh-colored, erythematous, or brown/black
  • Extensor surfaces of the arms and legs and on the trunk
  • Upper back, abdomen, and sacrum
Worsened by heat, sweating, or irritation from clothing
  • Thick, compact orthohyperkeratosis
  • Irregular epidermal hyperplasia or pseudoepitheliomatous hyperplasia
  • Focal parakeratosis with irregular acanthosis
  • Diminished nerve fiber density
  • A nonspecific dermal infiltrate containing lymphocytes, macrophages, eosinophils, and neutrophils
Nodules range in number from few to hundreds

upper midback area is usually spared

Common nevus
  • Dome-shaped, usually nonpigmented or hypopigmented nodules with a smooth surface
  • Terminal hairs are often present
  • Comma-shaped or curved vessels
  • Structureless skin-colored to light brown background pigmentation
  • Residual brown globules (clods) or brown thick circles, mainly located around the hair follicles can sometimes be seen
Blue nevus
  • Bluish macules or papules
  • Structureless blue pigmentation
  • Structureless blue and white or blue and brown on some occasions
  • Head and neck,
  • Dorsal aspect of the distal extremities
  • Sacral area
Spitz nevus Nonpigmented Spitz nevus coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background benign, indolent melanocyte proliferation that most commonly develops in children, adolescents, and young adults.
Reed-like Spitz coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background benign, indolent melanocyte proliferation that most commonly develops in children, adolescents, and young adults.
Solar lentigo
Lentigo Maligna
Lentigo Maligna Melanoma
Sebaceous hyperplasia
Lichen planus-like keratosis
Seborrheic keratosis
Actinic keratosis less pigmentation, and tend to be somewhat smaller in size. Erythema Hyperkeratosis painful
Nodular malignant melanoma Lump that has been rapidly growing over the past weeks No more additional findings none No more additional findings Cells proliferate downwards through the skin (vertical growth)
  • Two-thirds arise in normal skin, the rest in existing moles
  • Genetic component in some cases with a positive family history
Amelanotic melanoma Color usually pink, purple or normal skin color Usually have an asymmetrical shape with an irregular border Red, nonspecific lesion with slightly elevated borders
  • Do not make melanin, so lesions are not pigmented

SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.